Holen Sie sich die Stockscreener-App
10.56
0.09%
-0.010
Handel nachbörslich:
10.56
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Forum
Prognose
Aktiensplit
Dividendenhistorie
Schlusskurs vom Vortag:
$10.57
Offen:
$10.6
24-Stunden-Volumen:
6.94M
Relative Volume:
0.75
Marktkapitalisierung:
$12.16B
Einnahmen:
$14.33B
Nettoeinkommen (Verlust:
$-3.79B
KGV:
-3.3312
EPS:
-3.17
Netto-Cashflow:
$1.84B
1W Leistung:
-1.40%
1M Leistung:
+2.03%
6M Leistung:
+27.38%
1J Leistung:
-20.96%
1-Tages-Spanne:
$10.52
$10.73
1-Wochen-Bereich:
$10.15
$10.73
52-Wochen-Spanne:
$6.85
$13.33
Viatris Inc Stock (VTRS) Company Profile
Firmenname
Viatris Inc
Sektor
Telefon
(724) 514-1465
Adresse
1000 MYLAN BOULEVARD, CANONSBURG
Vergleichen Sie VTRS mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
VTRS
Viatris Inc
|
10.56 | 12.17B | 14.33B | -3.79B | 1.84B | -3.17 |
|
ZTS
Zoetis Inc
|
127.89 | 54.15B | 9.40B | 2.65B | 2.24B | 5.935 |
|
TAK
Takeda Pharmaceutical Co Adr
|
14.50 | 44.92B | 29.63B | 260.53M | 5.51B | 0.0788 |
|
HLN
Haleon Plc Adr
|
9.82 | 43.06B | 14.26B | 1.98B | 2.47B | 0.4327 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
24.99 | 28.42B | 16.70B | -157.13M | 1.19B | -0.1446 |
|
UTHR
United Therapeutics Corp
|
485.77 | 20.55B | 3.08B | 1.24B | 1.07B | 25.61 |
Viatris Inc Stock (VTRS) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-10-15 | Eingeleitet | Truist | Buy |
| 2025-06-06 | Eingeleitet | Goldman | Neutral |
| 2024-07-19 | Fortgesetzt | Jefferies | Buy |
| 2023-10-23 | Herabstufung | BofA Securities | Neutral → Underperform |
| 2023-06-23 | Herabstufung | Barclays | Equal Weight → Underweight |
| 2023-04-24 | Herabstufung | Barclays | Overweight → Equal Weight |
| 2023-02-17 | Herabstufung | BMO Capital Markets | Outperform → Market Perform |
| 2023-01-27 | Hochstufung | Jefferies | Hold → Buy |
| 2022-11-10 | Hochstufung | UBS | Sell → Neutral |
| 2022-11-08 | Hochstufung | Piper Sandler | Underweight → Neutral |
| 2022-10-21 | Fortgesetzt | Jefferies | Hold |
| 2022-06-14 | Eingeleitet | UBS | Sell |
| 2022-05-10 | Herabstufung | Piper Sandler | Neutral → Underweight |
| 2022-03-01 | Herabstufung | BofA Securities | Buy → Neutral |
| 2022-03-01 | Herabstufung | Raymond James | Outperform → Mkt Perform |
| 2021-06-15 | Eingeleitet | Citigroup | Neutral |
| 2021-04-07 | Fortgesetzt | RBC Capital Mkts | Outperform |
| 2021-03-08 | Herabstufung | Goldman | Buy → Neutral |
| 2021-03-02 | Herabstufung | JP Morgan | Overweight → Neutral |
| 2021-02-26 | Herabstufung | Wolfe Research | Outperform → Peer Perform |
| 2021-01-05 | Eingeleitet | Argus | Hold |
| 2020-12-14 | Eingeleitet | Bernstein | Mkt Perform |
Alle ansehen
Viatris Inc Aktie (VTRS) Neueste Nachrichten
Merz fails with PI request in first ever SPC case against Viatris - JUVE Patent
Fondaparinux Market Set to Significantly Grow from 2025 to 2032 | - openPR.com
Viatris to Participate in Upcoming Investor Conferences - PR Newswire
Pfizer, UnitedHealth, Viatris, Addus HomeCare, and Quest Stocks Trade Up, What You Need To Know - The Globe and Mail
Is Viatris Inc. (VIA) stock inflation resilientJuly 2025 Price Swings & Verified Trade Idea Suggestions - newser.com
Can Viatris Inc. (VIA) stock sustain double digit ROETrade Risk Report & Long-Term Safe Investment Plans - newser.com
What market sentiment indicators show for Viatris Inc. (VIA) stockJuly 2025 Spike Watch & Real-Time Stock Entry Alerts - newser.com
Can Viatris Inc. (VIA) stock test all time highsJuly 2025 Sector Moves & Fast Exit Strategy with Risk Control - newser.com
(VTRS) Movement Within Algorithmic Entry Frameworks - news.stocktradersdaily.com
Ex-Dividend Reminder: Viatris, Radian Group and Equitable Holdings - Nasdaq
European study shows falling prices, rising costs and shortagesfindings from independent study presented during World AMR Awareness Week by Viatris and Medicines for Europe | Corporate - EQS News
Is Viatris Inc. stock supported by strong cash flowsInsider Buying & Comprehensive Market Scan Insights - newser.com
How Viatris Inc. (VIA) stock trades pre earningsQuarterly Profit Report & Comprehensive Market Scan Insights - newser.com
Europäische Studie zeigt sinkende Preise, steigende Kosten und EngpässeErgebnisse einer unabhängigen Studie, die während der World AMR Awareness Week von Viatris und Medicines for Europe vorgestellt wurden - PR Newswire
Is it time to cut losses on Viatris Inc.Weekly Trend Recap & Real-Time Stock Entry Alerts - newser.com
Is Viatris Inc. stock recession proof2025 Price Momentum & Risk Controlled Daily Trade Plans - newser.com
What technical charts say about Viatris Inc. stockJuly 2025 Closing Moves & Safe Capital Growth Stock Tips - newser.com
Will Viatris Inc. (VIA) stock benefit from commodity supercycle2025 Price Targets & Entry Point Confirmation Alerts - newser.com
Why Viatris Inc. stock could be next big winnerJuly 2025 Breakouts & Detailed Earnings Play Strategies - newser.com
Will Viatris Inc. stock recover faster than peersMarket Trend Review & Risk Adjusted Buy and Sell Alerts - newser.com
Can Viatris Inc. (VIA) stock surprise markets with earningsInflation Watch & Safe Entry Point Identification - newser.com
United States General Anesthesia Drugs Market Insights & Growth - openPR.com
What dividend safety score for Viatris Inc. stockJuly 2025 Spike Watch & Low Risk Profit Maximizing Plans - newser.com
Viatris Inc. stock outlook for YEARTrend Reversal & Fast Exit/Entry Strategy Plans - newser.com
Using AI based signals to follow Viatris Inc.2025 Key Lessons & Real-Time Buy Zone Alerts - newser.com
Viatris Inc. - Ad-hoc-news.de
Viatris Inc. (0A5V.L) Stock Price, News, Quote & History - Yahoo! Finance Canada
Is Viatris Inc. stock a good choice for value investorsWeekly Risk Summary & Growth Focused Stock Reports - newser.com
What does recent volatility data suggest for Viatris Inc.Oil Prices & Growth Focused Stock Reports - newser.com
Viatris at Jefferies Conference: Strategic Growth Plans - Investing.com India
Finanzdaten der Viatris Inc-Aktie (VTRS)
Umsatz
Nettogewinn
Free Cashflow
ENV
1.47%
1.83%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):